{"id":"istp-dp","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Diarrhea"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL5776166","moleculeType":null,"molecularWeight":"557.40"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ISTp-DP works by modulating the immune response to prevent rejection in organ transplant patients. It is a form of immunosuppressive therapy that helps to reduce the risk of graft rejection and improve patient outcomes.","oneSentence":"ISTp-DP is a drug that targets the immune system to treat various conditions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:20.791Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of organ rejection in transplant patients"}]},"trialDetails":[{"nctId":"NCT01669941","phase":"PHASE4","title":"Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya","status":"COMPLETED","sponsor":"Kenya Medical Research Institute","startDate":"2012-08","conditions":"Pregnancy, Malaria","enrollment":1546}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Eurartesim","Duocotexin"],"phase":"marketed","status":"active","brandName":"ISTp-DP","genericName":"ISTp-DP","companyName":"Kenya Medical Research Institute","companyId":"kenya-medical-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ISTp-DP is a drug that targets the immune system to treat various conditions. Used for Prevention of organ rejection in transplant patients.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}